Clinical Trial Update: Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR [NA]

View source ↗

Summary

Clinical trial update on donor-derived humoral immunity and hematopoietic stem cell transplantation completed with posted results in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Hodgkin Lymphoma
• Myelodysplastic Syndrome
• Myelogenous Leukemia
• Non-hodgkin Lymphoma

Snippet

Sponsor: Robert Krance | Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia | NA | Status: COMPLETED | Results posted: 2020-04-21